ASO Author Reflections: Delayed Occurrence and Postoperative Risks of Mitomycin-C-Induced Neutropenia After Hyperthermic Intraperitoneal Chemotherapy

Ann Surg Oncol. 2022 Mar;29(3):2087-2088. doi: 10.1245/s10434-021-11000-2. Epub 2021 Oct 23.

Authors

Eun Jung Park¹, Suk Jun Lee², Seung Hyuk Baik³

Affiliations

¹ Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. camp79@yuhs.ac.
² Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
³ Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

PMID: 34689262
DOI: 10.1245/s10434-021-11000-2

No abstract available

MeSH terms

Combined Modality Therapy
Cytoreduction Surgical Procedures / adverse effects
Humans
Hyperthermia, Induced* / adverse effects
Hyperthermic Intraperitoneal Chemotherapy
Mitomycin / adverse effects
Neutropenia* / chemically induced
Peritoneal Neoplasms* / drug therapy

Substances

Mitomycin